{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:12:38Z","timestamp":1788412358483,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009881","name":"Regione Liguria","doi-asserted-by":"publisher","award":["NET-2019-12371188 GLI-HOPE"],"award-info":[{"award-number":["NET-2019-12371188 GLI-HOPE"]}],"id":[{"id":"10.13039\/501100009881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s11307-022-01769-3","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T17:04:46Z","timestamp":1661879086000},"page":"391-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diagnostic and Dosimetry Features of [64Cu]CuCl2 in High-Grade Paediatric Infiltrative Gliomas"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3932-1330","authenticated-orcid":false,"given":"Francesco","family":"Fiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Bottoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Righi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Cirone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmen","family":"Garganese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Verrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Milanaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Ramaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mastronuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo Eraldo","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Cacchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Gandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna Stefania","family":"Colafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Garr\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Morana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Piccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"1769_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.21037\/atm.2018.05.11","volume":"6","author":"A Blionas","year":"2018","unstructured":"Blionas A, Giakoumettis D, Klonou A et al (2018) Paediatric gliomas: diagnosis, molecular biology and management. Ann Transl Med 6:251","journal-title":"Ann Transl Med"},{"key":"1769_CR2","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.4081\/rt.2017.6552","volume":"9","author":"V Immanuel","year":"2017","unstructured":"Immanuel V, Kingsley PA, Negi P et al (2017) Variegated colors of pediatric glioblastoma multiforme: what to expect? Rare Tumors 9:6552","journal-title":"Rare Tumors"},{"key":"1769_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10555-019-09824-2","volume":"38","author":"WM Rashed","year":"2019","unstructured":"Rashed WM, Maher E, Adel M et al (2019) Pediatric diffuse intrinsic pontine glioma: where do we stand? Cancer Metastasis Rev 38:759\u2013770","journal-title":"Cancer Metastasis Rev"},{"key":"1769_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251","journal-title":"Neuro Oncol"},{"key":"1769_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/0971-5851.103142","volume":"33","author":"M Ansari","year":"2012","unstructured":"Ansari M, Nasrolahi H, Kani AA et al (2012) Pediatric glioblastoma multiforme: a single-institution experience. Indian J Med Paediatr Oncol 33:155\u2013160","journal-title":"Indian J Med Paediatr Oncol"},{"key":"1769_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3171\/2016.8.PEDS1631","volume":"19","author":"SK Konar","year":"2017","unstructured":"Konar SK, Bir SC, Maiti TK et al (2017) A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord. J Neurosurg Pediatr 19:239\u2013248","journal-title":"J Neurosurg Pediatr"},{"key":"1769_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuchi.2019.03.001","volume":"65","author":"O Boudaouara","year":"2019","unstructured":"Boudaouara O, Charfi S, Bahri M et al (2019) Pediatric high grade gliomas: clinico-pathological profile, therapeutic approaches and factors affecting overall survival. Neurochirurgie 65:63\u201368","journal-title":"Neurochirurgie"},{"key":"1769_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s11910-013-0346-3","volume":"13","author":"SA Grimm","year":"2013","unstructured":"Grimm SA, Chamberlain MC (2013) Brainstem glioma: a review. Curr Neurol Neurosci Rep 13:346","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1769_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/14737175.2020.1775584","volume":"20","author":"J Felker","year":"2020","unstructured":"Felker J, Broniscer A (2020) Improving long-term survival in diffuse intrinsic pontine glioma. Expert Rev Neurother 20:647\u2013658","journal-title":"Expert Rev Neurother"},{"key":"1769_CR10","doi-asserted-by":"publisher","first-page":"102216","DOI":"10.1016\/j.nano.2020.102216","volume":"28","author":"G Covarrubias","year":"2020","unstructured":"Covarrubias G, Johansen ML, Vincent J et al (2020) PTPmu-targeted nanoparticles label invasive pediatric and adult glioblastoma. Nanomedicine 28:102216","journal-title":"Nanomedicine"},{"key":"1769_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/neuonc\/noy145","volume":"21","author":"NAP Lieberman","year":"2019","unstructured":"Lieberman NAP, DeGolier K, Kovar HM et al (2019) Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro Oncol 21:83\u201394","journal-title":"Neuro Oncol"},{"key":"1769_CR12","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/pbc.26031","volume":"63","author":"JE Shabason","year":"2016","unstructured":"Shabason JE, Sutton D, Kenton O et al (2016) Patterns of failure for pediatric glioblastoma multiforme following radiation therapy. Pediatr Blood Cancer 63:1465\u20131467","journal-title":"Pediatr Blood Cancer"},{"key":"1769_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fonc.2012.00105","volume":"2","author":"J Fangusaro","year":"2012","unstructured":"Fangusaro J (2012) Pediatric high grade glioma: a review and update on tumor clinical characteristics and biology. Front Oncol 2:105","journal-title":"Front Oncol"},{"key":"1769_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/neuonc\/noq191","volume":"13","author":"KJ Cohen","year":"2011","unstructured":"Cohen KJ, Pollack IF, Zhou T et al (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children\u2019s Oncology Group. Neuro Oncol 13:317\u2013323","journal-title":"Neuro Oncol"},{"key":"1769_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijrobp.2012.04.006","volume":"85","author":"GO Janssens","year":"2013","unstructured":"Janssens GO, Jansen MH, Lauwers SJ et al (2013) Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis. Int J Radiat Oncol Biol Phys 85:315\u2013320","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1769_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejca.2016.12.007","volume":"73","author":"GO Janssens","year":"2017","unstructured":"Janssens GO, Gandola L, Bolle S et al (2017) Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG\/DIPG working group. Eur J Cancer 73:38\u201347","journal-title":"Eur J Cancer"},{"key":"1769_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jocn.2019.12.001","volume":"72","author":"MB Janjua","year":"2020","unstructured":"Janjua MB, Ban VS, El Ahmadieh TY et al (2020) Diffuse intrinsic pontine gliomas: diagnostic approach and treatment strategies. J Clin Neurosci 72:15\u201319","journal-title":"J Clin Neurosci"},{"key":"1769_CR18","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/1078-0432.CCR-18-3890","volume":"25","author":"H Katagi","year":"2019","unstructured":"Katagi H, Louis N, Unruh D et al (2019) Radiosensitization by Histone H3 demethylase inhibition in diffuse intrinsic pontine glioma. Clin Cancer Res 25:5572\u20135583","journal-title":"Clin Cancer Res"},{"key":"1769_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s13566-013-0132-5","volume":"3","author":"M Christensen","year":"2014","unstructured":"Christensen M, Kamson DO, Snyder M et al (2014) Tryptophan PET-defined gross tumor volume offers better coverage of initial progression than standard MRI-based planning in glioblastoma patients. J Radiat Oncol 3:131\u2013138","journal-title":"J Radiat Oncol"},{"key":"1769_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00259-018-4207-9","volume":"46","author":"I Law","year":"2019","unstructured":"Law I, Albert NL, Arbizu J et al (2019) Joint EANM\/EANO\/RANO practice guidelines\/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0. Eur J Nucl Med Mol Imaging 46:540\u2013557","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1769_CR21","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/147323000703500301","volume":"35","author":"E Huskisson","year":"2007","unstructured":"Huskisson E, Maggini S, Ruf M (2007) The role of vitamins and minerals in energy metabolism and well-being. J Int Med Res 35:277\u2013289","journal-title":"J Int Med Res"},{"key":"1769_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/iub.50","volume":"60","author":"D Horn","year":"2008","unstructured":"Horn D, Barrientos A (2008) Mitochondrial copper metabolism and delivery to cytochrome c oxidase. IUBMB Life 60:421\u2013429","journal-title":"IUBMB Life"},{"key":"1769_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature13180","volume":"509","author":"DC Brady","year":"2014","unstructured":"Brady DC, Crowe MS, Turski ML et al (2014) Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature 509:492\u2013496","journal-title":"Nature"},{"key":"1769_CR24","doi-asserted-by":"publisher","first-page":"19507","DOI":"10.1073\/pnas.1318431110","volume":"110","author":"S Ishida","year":"2013","unstructured":"Ishida S, Andreux P, Poitry-Yamate C et al (2013) Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci U S A 110:19507\u201319512","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1769_CR25","doi-asserted-by":"publisher","first-page":"118893","DOI":"10.1016\/j.bbamcr.2020.118893","volume":"1868","author":"VC Shanbhag","year":"2021","unstructured":"Shanbhag VC, Gudekar N, Jasmer K et al (2021) Copper metabolism as a unique vulnerability in cancer. Biochim Biophys Acta Mol Cell Res 1868:118893","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1769_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","volume":"39","author":"L Cui","year":"2021","unstructured":"Cui L, Gouw AM, LaGory EL et al (2021) Mitochondrial copper depletion suppresses triple-negative breast cancer in mice. Nat Biotechnol 39:357\u2013367","journal-title":"Nat Biotechnol"},{"issue":"9","key":"1769_CR27","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/cells8091080","volume":"8","author":"R Petruzzelli","year":"2019","unstructured":"Petruzzelli R, Polishchuk RS (2019) Activity and trafficking of copper-transporting ATPases in tumor development and defense against platinum-based drugs. Cells 8(9):1080","journal-title":"Cells"},{"key":"1769_CR28","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00259-005-1906-9","volume":"32","author":"HA Williams","year":"2005","unstructured":"Williams HA, Robinson S, Julyan P et al (2005) A comparison of PET imaging characteristics of various copper radioisotopes. Eur J Nucl Med Mol Imaging 32:1473\u20131480","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1769_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.23736\/S1824-4785.20.03292-6","volume":"64","author":"C Bolzati","year":"2020","unstructured":"Bolzati C, Duatti A (2020) The emerging value of 64Cu for molecular imaging and therapy. Q J Nucl Med Mol Imaging 64:329\u2013337","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1769_CR30","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.apradiso.2012.02.056","volume":"70","author":"MM B\u00e9","year":"2012","unstructured":"B\u00e9 MM, Cassette P, L\u00e9py MC et al (2012) Standardization, decay data measurements and evaluation of 64Cu. Appl Radiat Isot 70:1894\u20131899","journal-title":"Appl Radiat Isot"},{"key":"1769_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13550-018-0373-9","volume":"8","author":"S Righi","year":"2018","unstructured":"Righi S, Ugolini M, Bottoni G et al (2018) Biokinetic and dosimetric aspects of (64)CuCl(2) in human prostate cancer: possible theranostic implications. EJNMMI Res 8:18","journal-title":"EJNMMI Res"},{"key":"1769_CR32","first-page":"159","volume":"31","author":"P Panichelli","year":"2016","unstructured":"Panichelli P, Villano C, Cistaro A et al (2016) Imaging of brain tumors with copper-64 chloride: early experience and results. Cancer Biother Radiopharm 31:159\u2013167","journal-title":"Cancer Biother Radiopharm"},{"key":"1769_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0969-8051(96)00157-6","volume":"24","author":"DW McCarthy","year":"1997","unstructured":"McCarthy DW, Shefer RE, Klinkowstein RE et al (1997) Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol 24:35\u201343","journal-title":"Nucl Med Biol"},{"key":"1769_CR34","doi-asserted-by":"crossref","unstructured":"ICRP (1995) Basic anatomical & physiological data for use in radiological protection: the skeleton: the Skeleton. ICRP Publication 70. Ann ICRP\u00a025:1\u201380","DOI":"10.1016\/S0146-6453(00)80004-4"},{"key":"1769_CR35","first-page":"37s","volume":"40","author":"JA Siegel","year":"1999","unstructured":"Siegel JA, Thomas SR, Stubbs JB et al (1999) MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 40:37s\u201361s","journal-title":"J Nucl Med"},{"key":"1769_CR36","unstructured":"Loeevinger R, Berman M (1968) A schema for absorbed-dose calculations for biologically-distributed radionuclides. J Nucl Med. Suppl 1:9\u201314"},{"key":"1769_CR37","unstructured":"Snyder W, Ford, Warner GG, et al (1975) MIRD Pamphlet #11: S, absorbed dose per unit cumulated activity for selected radionuclides and organs"},{"key":"1769_CR38","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E (2005) OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 46:1023\u20131027","journal-title":"J Nucl Med"},{"key":"1769_CR39","doi-asserted-by":"crossref","unstructured":"ICRP (2007) The 2007 Recommendations of the International Commission on Radiological Protection (2007) ICRP publication 103. Ann ICRP\u00a037:1\u2013332","DOI":"10.1016\/j.icrp.2008.07.001"},{"key":"1769_CR40","doi-asserted-by":"crossref","unstructured":"ICRP (1991) 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60.\u00a0Ann ICRP\u00a021:1\u20133","DOI":"10.1016\/0146-6453(91)90066-P"},{"key":"1769_CR41","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/S1470-2045(20)30166-2","volume":"21","author":"TM Cooney","year":"2020","unstructured":"Cooney TM, Cohen KJ, Guimaraes CV et al (2020) Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 21:e330\u2013e336","journal-title":"Lancet Oncol"},{"key":"1769_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13550-019-0586-6","volume":"9","author":"EA P\u00e9r\u00e8s","year":"2019","unstructured":"P\u00e9r\u00e8s EA, Toutain J, Paty LP et al (2019) (64)Cu-ATSM\/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study. EJNMMI Res 9:114","journal-title":"EJNMMI Res"},{"key":"1769_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3174\/ajnr.A3679","volume":"35","author":"K Tateishi","year":"2014","unstructured":"Tateishi K, Tateishi U, Nakanowatari S et al (2014) (62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET. AJNR Am J Neuroradiol 35:278\u2013284","journal-title":"AJNR Am J Neuroradiol"},{"key":"1769_CR44","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1007\/s00259-017-3777-2","volume":"44","author":"G Morana","year":"2017","unstructured":"Morana G, Piccardo A, Tortora D et al (2017) Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET. Eur J Nucl Med Mol Imaging 44:2084\u20132093","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1769_CR45","doi-asserted-by":"publisher","first-page":"11881","DOI":"10.7150\/thno.50598","volume":"10","author":"G Morana","year":"2020","unstructured":"Morana G, Tortora D, Bottoni G et al (2020) Correlation of multimodal (18)F-DOPA PET and conventional MRI with treatment response and survival in children with diffuse intrinsic pontine gliomas. Theranostics 10:11881\u201311891","journal-title":"Theranostics"},{"key":"1769_CR46","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00259-019-04333-4","volume":"46","author":"A Piccardo","year":"2019","unstructured":"Piccardo A, Tortora D, Mascelli S et al (2019) Advanced MR imaging and (18)F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas. Eur J Nucl Med Mol Imaging 46:1685\u20131694","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1769_CR47","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1200\/JCO.2017.76.0611","volume":"36","author":"J Grill","year":"2018","unstructured":"Grill J, Massimino M, Bouffet E et al (2018) Phase II, Open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma. J Clin Oncol 36:951\u2013958","journal-title":"J Clin Oncol"},{"key":"1769_CR48","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nou104","volume":"17","author":"MH Jansen","year":"2015","unstructured":"Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E et al (2015) Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 17:160\u2013166","journal-title":"Neuro Oncol"},{"key":"1769_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.21037\/qims-19-954","volume":"11","author":"S Thust","year":"2021","unstructured":"Thust S, Micallef C, Okuchi S et al (2021) Imaging characteristics of H3 K27M histone-mutant diffuse midline glioma in teenagers and adults. Quant Imaging Med Surg 11:43\u201356","journal-title":"Quant Imaging Med Surg"},{"key":"1769_CR50","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/neuonc\/noaa140","volume":"22","author":"JL Leach","year":"2020","unstructured":"Leach JL, Roebker J, Schafer A et al (2020) MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry. Neuro Oncol 22:1647\u20131657","journal-title":"Neuro Oncol"},{"key":"1769_CR51","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/neuonc\/now258","volume":"19","author":"N Colwell","year":"2017","unstructured":"Colwell N, Larion M, Giles AJ et al (2017) Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol 19:887\u2013896","journal-title":"Neuro Oncol"},{"key":"1769_CR52","doi-asserted-by":"crossref","unstructured":"Nobre L, Zapotocky M, Ramaswamy V, et al (2020) Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition. JCO Precis Oncol\u00a04:PO.19.00298","DOI":"10.1200\/PO.19.00298"},{"key":"1769_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2307\/3574422","volume":"67","author":"PC Chan","year":"1976","unstructured":"Chan PC, Lisco E, Lisco H et al (1976) The radiotoxicity of iodine-125 in mammalian cells II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131TUdR, and 3HTdR. Radiat Res 67:332\u2013343","journal-title":"Radiat Res"},{"key":"1769_CR54","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2307\/3575714","volume":"90","author":"AI Kassis","year":"1982","unstructured":"Kassis AI, Adelstein SJ, Haydock C et al (1982) Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. Radiat Res 90:362\u2013373","journal-title":"Radiat Res"},{"key":"1769_CR55","first-page":"59","volume":"26","author":"AI Kassis","year":"1985","unstructured":"Kassis AI, Sastry KS, Adelstein SJ (1985) Intracellular distribution and radiotoxicity of chromium-51 in mammalian cells: Auger-electron dosimetry. J Nucl Med 26:59\u201367","journal-title":"J Nucl Med"},{"key":"1769_CR56","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2967\/jnumed.117.195628","volume":"59","author":"A Piccardo","year":"2018","unstructured":"Piccardo A, Paparo F, Puntoni M et al (2018) (64)CuCl(2) PET\/CT in prostate cancer relapse. J Nucl Med 59:444\u2013451","journal-title":"J Nucl Med"},{"key":"1769_CR57","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/sj.bjc.6604833","volume":"100","author":"A Bohlken","year":"2009","unstructured":"Bohlken A, Cheung BB, Bell JL et al (2009) ATP7A is a novel target of retinoic acid receptor \u03b22 in neuroblastoma cells. Br J Cancer 100:96\u2013105","journal-title":"Br J Cancer"},{"key":"1769_CR58","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.7150\/thno.29840","volume":"8","author":"A Parmar","year":"2018","unstructured":"Parmar A, Pascali G, Voli F et al (2018) In vivo [64 Cu]CuCl 2 PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasis. Theranostics 8:5645\u20135659","journal-title":"Theranostics"},{"key":"1769_CR59","first-page":"495","volume":"36","author":"D Kilari","year":"2016","unstructured":"Kilari D, Icykowski KA, Pandya C et al (2016) copper transporter-CTR1 expression and pathological outcomes in platinum-treated muscle-invasive bladder cancer patients. Anticancer Res 36:495\u2013501","journal-title":"Anticancer Res"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-022-01769-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-022-01769-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-022-01769-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T19:06:27Z","timestamp":1678475187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-022-01769-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1007\/s11307-022-01769-3","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}